Drugs / THC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05427630 | Feb 2023 → Dec 2027 | migraine disorder | University of California, San Diego | Suspended | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | THC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05427630 ↗ |
| Route | Inhaled | “Inhaled cannabis will be administered using a portable system.” NCT05427630 ↗ |